| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adaptive cancer treatment: why I put my money on immunotherapy
|
Porrata, Luis F
|
|
2015
|
2 |
10 |
p. e402-e403
nvt p.
|
article
|
| 2 |
Aging and transplanting graciously
|
de Lima, Marcos
|
|
2015
|
2 |
10 |
p. e398-e399
nvt p.
|
article
|
| 3 |
Correction to Lancet Haematol 2015; 2: e315
|
|
|
2015
|
2 |
10 |
p. e407-
1 p.
|
article
|
| 4 |
Eltrombopag in patients with high-risk myelodysplastic syndrome or acute myeloid leukaemia: cautious optimism
|
Buckstein, Rena
|
|
2015
|
2 |
10 |
p. e396-e397
nvt p.
|
article
|
| 5 |
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
|
Huntington, Scott F
|
|
2015
|
2 |
10 |
p. e408-e416
nvt p.
|
article
|
| 6 |
Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: a case-control and a cohort study
|
Uyoga, Sophie
|
|
2015
|
2 |
10 |
p. e437-e444
nvt p.
|
article
|
| 7 |
G6PD deficiency: a polymorphism balanced by heterozygote advantage against malaria
|
Luzzatto, Lucio
|
|
2015
|
2 |
10 |
p. e400-e401
nvt p.
|
article
|
| 8 |
INWORKS study: risk of leukaemia from protracted radiation exposure
|
Doss, Mohan
|
|
2015
|
2 |
10 |
p. e404-e405
nvt p.
|
article
|
| 9 |
INWORKS study: risk of leukaemia from protracted radiation exposure
|
Nagataki, Shigenobu
|
|
2015
|
2 |
10 |
p. e404-
1 p.
|
article
|
| 10 |
INWORKS study: risk of leukaemia from protracted radiation exposure – Authors' reply
|
Schubauer-Berigan, Mary K
|
|
2015
|
2 |
10 |
p. e405-e406
nvt p.
|
article
|
| 11 |
Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis
|
Versluis, Jurjen
|
|
2015
|
2 |
10 |
p. e427-e436
nvt p.
|
article
|
| 12 |
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study
|
Keane, Colm
|
|
2015
|
2 |
10 |
p. e445-e455
nvt p.
|
article
|
| 13 |
Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial
|
Platzbecker, Uwe
|
|
2015
|
2 |
10 |
p. e417-e426
nvt p.
|
article
|
| 14 |
The overlooked COST of multiple myeloma
|
de Souza, Jonas A
|
|
2015
|
2 |
10 |
p. e394-e395
nvt p.
|
article
|
| 15 |
Thromboembolism: an under appreciated cause of death
|
The Lancet Haematology,
|
|
2015
|
2 |
10 |
p. e393-
1 p.
|
article
|
Journal description